ACC 2020 ARTICLES

Acute coronary syndromes

Virtual ACC 2020 | TICO: Ticagrelor Monotherapy in Acute Coronary Syndromes

Switching to ticagrelor monotherapy after 3 months of dual antiplatelet therapy reduces major bleeding without paying a price...

solaci - 6 April, 2020

Antithrombotic Anticoagulants

Virtual ACC 2020 | PRONOMOS: Rivaroxaban Superior to Enoxaparin in Orthopedic Surgery

According to this new study presented virtually at the suspended American College of Cardiology (ACC) 2020 Scientific...

solaci - 6 April, 2020

Peripheral vascular disease

Virtual ACC 2020 | Renal Denervation Arises with New Evidence

In patients with uncontrolled hypertension who do not comply with treatment, renal denervation can generate benefit by...

solaci - 4 April, 2020

Chronic Ischemic cardiopathy

Virtual ACC 2020 | ISCHEMIA-CKD: Invasive Strategy vs. Medical Treatment in Higher Risk Patients

This pre-specified protocol originally included 777 patients with chronic kidney failure. These patients are a special population...

solaci - 3 April, 2020

Antithrombotic Anticoagulants

Virtual ACC 2020 | CARAVAGGIO: Apixaban in Venous Thromboembolism Associated to Cancer

Oral apixaban resulted non-inferior to subcutaneous dalteparin in the treatment of venous thromboembolism associated to cancer with...

solaci - 3 April, 2020

CORONARY DISEASE

Virtual ACC 2020 | PRECOMBAT: 10 Years for Surgery vs. Angioplasty in Left Main Coronary Artery Disease

After 10 years of follow-up, there were no significant differences in the rates of major adverse cardiovascular or...

solaci - 2 April, 2020

Antiplatelet

Virtual ACC 2020 | TWILIGHT-COMPLEX: Ticagrelor Monotherapy in the Most “Dangerous” Angioplasties

The original TWILIGHT findings in more than 9000 patients who underwent angioplasty were presented last year at TCT...

solaci - 2 April, 2020

Structural heart disease

Virtual ACC 2020 | First Results of Evolut in Low-Risk Bicuspid Valves

The initial results of this study presented “virtually” at the American College of Cardiology (ACC) 2020 Scientific...

solaci - 2 April, 2020

ACC 2020 ARTICLES

Virtual ACC 2020 | TICO: Ticagrelor Monotherapy in Acute Coronary Syndromes

Virtual ACC 2020 | PRONOMOS: Rivaroxaban Superior to Enoxaparin in Orthopedic Surgery

Virtual ACC 2020 | Renal Denervation Arises with New Evidence

Virtual ACC 2020 | ISCHEMIA-CKD: Invasive Strategy vs. Medical Treatment in Higher Risk Patients

Virtual ACC 2020 | CARAVAGGIO: Apixaban in Venous Thromboembolism Associated to Cancer

Virtual ACC 2020 | PRECOMBAT: 10 Years for Surgery vs. Angioplasty in Left Main Coronary Artery Disease

Virtual ACC 2020 | TWILIGHT-COMPLEX: Ticagrelor Monotherapy in the Most “Dangerous” Angioplasties

Virtual ACC 2020 | First Results of Evolut in Low-Risk Bicuspid Valves

Últimas Noticias

Long Term Results of the International Chimney Registry

CANNULATE TAVR extended study: Impact of Commissural and Coronary Alignment in Coronary Cannulation Following TAVR with Evolut Fx

TRISCEND II: Transcatheter Replacement vs. Medical Treatment for Tricuspid Regurgitation

Noticias Institucionales

Hemodynamics and Interventional Cardioangiology Hybrid Training Course SOLACI-CACI

Check out the best images of the El Salvador 2024 Sessions

The El Salvador 2024 Sessions are coming soon

Accesos